Antibiotic exposure, infection, and the development of pediatric psoriasis a nested case-control study

JAMA Dermatology

Volumn 152, Issue 2, 2016, Pages 191-199

  Horton, Daniel B ^a,b,c   Scott, Frank I ^a,d   Haynes, Kevin ^a,e   Putt, Mary E ^a   Rose, Carlos D ^b   Lewis, James D ^a,d   Strom, Brian L ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e HealthCore   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; SULFONAMIDE; ANTIINFECTIVE AGENT;

ADOLESCENT; AGE; ARTICLE; CASE CONTROL STUDY; CHICKENPOX; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EXPOSURE; ELECTRONIC MEDICAL RECORD; FEMALE; GASTROINTESTINAL INFECTION; GENERAL PRACTICE; HERPES SIMPLEX; HUMAN; INFECTION; LOGISTIC REGRESSION ANALYSIS; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MATERNAL WELFARE; MOLLUSCUM CONTAGIOSUM; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; SCHOOL CHILD; SKIN INFECTION; SOCIAL STATUS; SOFT TISSUE INFECTION; TINEA; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION; VERRUCA VULGARIS; VIRUS INFECTION; COMPLICATION; FACTUAL DATABASE; INFANT; ISOLATION AND PURIFICATION; STATISTICAL MODEL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRUS DISEASES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; PSORIASIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED KINGDOM; VIRUS DISEASES;

EID: 84958012401     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.3650     Document Type: Article

References (47)

1. Matusiewicz D, Koerber A, Schadendorf D, Wasem J, Neumann A. Childhood psoriasis: An analysis of German health insurance data. Pediatr Dermatol. 2014;31(1):8-13.
2. Seminara NM, Abuabara K, Shin DB, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol. 2011;164(3):602-609.
3. Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J AmAcad Dermatol. 2014;70(1):146-167.
4. Mercy K, KwasnyM, Cordoro KM, et al. Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol. 2013;30(4):424-428.
5. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992;128(1): 39-42.
6. Krishnamurthy K, Walker A, Gropper CA, Hoffman C. To treat or not to treat? Management of guttate psoriasis and pityriasis rosea in patients with evidence of group A Streptococcal infection. J Drugs Dermatol. 2010;9(3):241-250.
7. Weitz M, Kiessling C, FriedrichM, et al. Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis. Exp Dermatol. 2011;20(7):561-567.
8. Johnson TM, DuvicM, Rapini RP, Rios A. AIDS exacerbates psoriasis. N Engl J Med. 1985;313(22): 1415.
9. Seetharam KA, Sridevi K. Chikungunya infection: A new trigger for psoriasis. J Dermatol. 2011;38(10): 1033-1034.
10. Tsankov N, Botev-Zlatkov N, Lazarova AZ, KostovaM, Popova L, Tonev S. Psoriasis and drugs: influence of tetracyclines on the course of psoriasis. J AmAcad Dermatol. 1988;19(4):629-632.
11. Tsankov NK, Vassileva SV, Lazarova AZ, Berowa NV, Botev-Zlatov N. Onset of psoriasis coincident with tetracycline therapy. Australas J Dermatol. 1988;29(2):111-112.
12. KatzM, Seidenbaum M, Weinrauch L. Penicillin-induced generalized pustular psoriasis. J AmAcad Dermatol. 1987;17(5, pt 2):918-920.
13. Kronman MP, Zaoutis TE, Haynes K, Feng R, Coffin SE. Antibiotic exposure and IBD development among children: A population-based cohort study. Pediatrics. 2012;130(4):e794-e803.
14. Arvonen M, Virta LJ, Pokka T, Kroer L, Valo P. Repeated exposure to antibiotics in infancy: A predisposing factor for juvenile idiopathic arthritis or a sign of this groups greater susceptibility to infections? J Rheumatol. 2015;42 (3):521-526.
15. Horton DB, Scott FI, Haynes K, et al. Antibiotic exposure and juvenile idiopathic arthritis: A case-control study. Pediatrics. 2015;136(2): e333-e343.
16. Stoll ML, Kumar R, Morrow CD, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther. 2014; 16(6):486.
17. Schwiertz A, Jacobi M, Frick JS, Richter M, Rusch K, Koler H. Microbiota in pediatric inflammatory bowel disease. J Pediatr. 2010;157(2): 240-244.e1.
18. Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128-139.
19. Alekseyenko AV, Perez-Perez GI, De Souza A, et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome. 2013;1(1):31-31.
20. Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251-255.
21. Austin PC, Anderson GM, Cigsar C, Gruneir A. Comparing the cohort design and the nested case-control design in the presence of both time-invariant and time-dependent treatment and competing risks: bias and precision. Pharmacoepidemiol Drug Saf. 2012;21(7):714-724.
22. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16(4):393-401.
23. Jernberg C, Lomark S, Edlund C, Jansson JK. Long-Term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1(1):56-66.
24. Marra F, Lynd L, CoombesM, et al. Does antibiotic exposure during infancy lead to development of asthma? a systematic review and metaanalysis. Chest. 2006;129(3):610-618.
25. Mai XM, Kull I, Wickman M, Bergstr A. Antibiotic use in early life and development of allergic diseases: respiratory infection as the explanation. Clin Exp Allergy. 2010;40(8):1230-1237.
26. Martqvist AK, Lundholm C, Kieler H, et al. Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis. BMJ. 2014;349:g6979.
27. Vangay P, Ward T, Gerber JS, Knights D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe. 2015;17(5):553-564.
28. Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014;63(4):559-566.
29. Sevelsted A, Stokholm J, Banelykke K, Bisgaard H. Cesarean section and chronic immune disorders. Pediatrics. 2015;135(1):e92-e98.
30. Wu Y, Lin Y, Liu HJ, Huang CZ, Feng AP, Li JW. Childhood psoriasis: A study of 137 cases from central China.World J Pediatr. 2010;6(3):260-264.
31. Nyfors A, Lemholt K. Psoriasis in children: A short review and a survey of 245 cases. Br J Dermatol. 1975;92(4):437-442.
32. Kumar B, Jain R, Sandhu K, Kaur I, Handa S. Epidemiology of childhood psoriasis: A study of 419 patients from northern India. Int J Dermatol. 2004;43(9):654-658.
33. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One. 2008;3(7):e2719.
34. Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol. 2013;169 (1):47-52.
35. Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449(7162):564-569.
36. Chen XY, Jin LW, Chen YW, et al. The association between the IL-20-1723C?G allele on the 1q chromosome and psoriasis triggered or exacerbated by an upper respiratory tract infection in the Chinese Han population. Dermatology. 2011; 222(1):24-30.
37. Nikamo P, Cheuk S, Lysell J, et al. Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T cells. J Invest Dermatol. 2014;134 (6):1535-1541.
38. Baroudjian B, Viguier M, Battistella M, et al. Psoriasis associated with idiopathic CD4+ T-cell lymphopenia: A regulatory T-cell defect? Br J Dermatol. 2014;171(1):186-189.
39. Paller AS, Mercy K, KwasnyMJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: An international cross-sectional study. JAMA Dermatol. 2013;149(2): 166-176.
40. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Scher I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633-636.
41. Becker L, TomWL, Eshagh K, Benjamin LT, Paller AS. Excess adiposity preceding pediatric psoriasis. JAMA Dermatol. 2014;150(5):573-574.
42. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014;168(11):1063-1069.
43. Ozden MG, Tekin NS, Goer MA, et al. Environmental risk factors in pediatric psoriasis: A multicenter case-control study. Pediatr Dermatol. 2011;28(3):306-312.
44. Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: A systematic review and meta-Analysis. Br J Dermatol. 2014; 170(2):304-314.
45. Soleymani T, Hung T, Soung J. The role of vitamin D in psoriasis: A review. Int J Dermatol. 2015;54(4):383-392.
46. Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: A population-based study. J AmAcad Dermatol. 2010;62(6):979-987.
47. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol. 2005;141 (12):1537-1541.